More than two dozen Black and Latino health tech leaders have endorsed Kamala Harris for president. Another group of over 500 ...

Most Americans don’t understand how an administration's view on healthcare data sharing interoperability could directly ...

After the FDA delayed the approval of MDMA-assisted therapy for PTSD, there's still a way forward for psychedelic medicines, experts said at HLTH.

In the life of a health system CEO, there is always something to worry about. This has been especially true for Tampa General Hospital CEO John Couris in the past few weeks. His organization has ...

Welcome back to another episode of MedCity FemFwd, a podcast dedicated to discussing the breakthroughs and challenges in women’s health. In this episode, we’re joined by Dr. Tiffany Inglis ...

From left to right: Tommy Ibrahim, president and CEO of Sanford Health Plan; and Scott Gottlieb, former commissioner of the FDA and partner at New Enterprise Associates Large language models (LLMs ...

Healthcare costs for employers are on the rise, and a large part of that is due to pharmacy expenses. Through a new partnership announced last week, HealthJoy and Mark Cuban Cost Plus Drug Company ...

The designer Charles Eames famously said, “Never delegate understanding.” I wholeheartedly agree. But, as a leader, I also recognize the value and necessity of learning from those who are ...

Alzheimer’s disease medicines commercialized in the past two years validated amyloid beta as a drug target, but these antibody therapies still have a hard time penetrating the membrane that ...

It’s hard for preclinical biotech companies to go public these days as investors look for human data that can reduce investment risk. Crescent Biopharma is more than a year away from the clinic ...

The molecular glue degrader medicines furthest along in development are potential cancer treatments, but Monte Rosa Therapeutics is also researching how this therapeutic modality can treat ...